Loading company…
Stamford-based digital health company using AI to match cancer patients with treatment options and clinical trials.
Founded in 2017 and headquartered in Stamford, US, Trialjectory Inc. runs an AI-driven tool that gives cancer patients personalized treatment options and clinical trial matches. The service is offered to patients, healthcare providers and pharmaceutical companies, mainly in the US and Canada. The company's CEO is Tzvia Bader, and in January 2022 it raised USD 20.00 mn in Series A funding led by Insight Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in